- Companies
- AG1
AG1 Revenue, Valuation, Funding & Investors
AG1 is valued at $1.2B as of January 2022, a 8.0x multiple on its last reported $150M revenue.
Last AG1 valuation
$1.2B
Undisclosed stage · Jan 2022
Last AG1 funding round
$115M
Undisclosed stage · Jan 2022
AG1 revenue
$150M
Undisclosed stage · Jan 2022
Key investors in AG1
Alpha Wave Global
About AG1
AG1 (formerly Athletic Greens) is a daily foundational nutrition powder that combines a multivitamin, probiotics, adaptogens, and superfoods into a single daily drink. It is designed to bridge nutrient gaps, support gut health, and boost sustained energy. Originally a pure-play DTC e-commerce brand, the company now offers products through premium brick-and-mortar retail (like Costco) and Amazon. After reaching roughly $160 million in revenue and raising $115 million at a $1.2 billion valuation in 2022, the company achieved $600 million in profitable annual revenue.
Founded
2010
HQ
Website
Status
Privately held
Customer focus
B2C
Revenue model
Subscription, Product sales
Revenue
$150M (Jan 2022)
Valuation
$1.2B (Jan 2022)
Sectors
AG1 Valuation
AG1 is currently valued at $1.2B, based on its undisclosed-stage round in January 2022.
The $115M round was led by Alpha Wave Global.
AG1 valuation by funding round
| Date | Stage | Valuation | Revenue Multiple |
|---|---|---|---|
| Jan 2022 | Undisclosed stage | $1.2B | 8.0x |
AG1 Revenue
AG1's latest recorded revenue is $150M, as of its undisclosed-stage round in January 2022. At a $1.2B valuation, that implies a 8.0x revenue multiple.
AG1 revenue by funding round
| Date | Revenue * | Valuation | Revenue Multiple | Stage |
|---|---|---|---|---|
| Jan 2022 | $150M | $1.2B | 8.0x | Undisclosed stage |
* Revenue (or ARR) figures are the values recorded alongside each funding round. Typically run-rate revenue at the time of the deal, or a reported LTM (last 12 months) revenue.
AG1 Funding History
AG1 has raised a total of $115M across 1 funding round.
AG1 funding rounds
| Date | Stage | Investors | Raised | Valuation | Deal Summary |
|---|---|---|---|---|---|
| Jan 2022 | Undisclosed stage | Alpha Wave Global (lead) | $115M | $1.2B | Athletic Greens, founded in 2010 by CEO Chris Ashenden, is a New Zealand-based nutrition company known for its flagship product AG1, a powdered foundational nutrition drink containing 75 vitamins, minerals, probiotics, whole food and adaptogenic ingredients designed to replace multiple wellness products in a single convenient serving. The company bootstrapped for over a decade before raising its first external investment in July 2021, at which point it had achieved a $150 million revenue run-rate. In January 2022, Athletic Greens announced a $115 million Series A-equivalent funding round led by Alpha Wave Ventures at a post-money valuation exceeding $1 billion, making it a unicorn. The round included participation from SC.Holdings, Bolt Ventures (David Blitzer's family office), and individual investors including Lewis Hamilton, Shawn Johnson, and entrepreneur Mark Vadon, among others. All investors were existing AG1 customers. The capital was allocated toward accelerating AG1 subscriber growth through increased digital and offline distribution, geographic expansion beyond North America, Europe, China and New Zealand, expanding production capacity, and funding scientific research and product innovation including development of new complementary products to complement AG1. |
Who has invested in AG1?
1 investor has backed AG1 across its funding rounds, including Alpha Wave Global.
Lead investors include Alpha Wave Global.
AG1 Investors
| Investor | HQ | Rounds | Role | First check |
|---|---|---|---|---|
This data is available for Pro users. Sign up to see all 1 AG1 investors. Start Free Trial | ||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAG1 Competitors
AG1 competitors include listed companies like Edgewell, Jamieson Wellness and Intercos, and private ones like The Good Glamm Group, Pharmapacks and GP Club.
| Company | HQ | Status | Revenue | EBITDA | Valuation | Revenue Multiple |
|---|---|---|---|---|---|---|
| Private | $120M | - | $1.2B | 10.0x | ||
| Publicly listed | $2.2B | $186M | $1.3B | 1.1x | ||
| Private | $250M | - | $1.1B | 4.4x | ||
| Private | - | - | $1.3B | - | ||
| Publicly listed | $589M | $95M | $1.4B | 2.6x | ||
| Publicly listed | $1.2B | $159M | $1.4B | 1.2x |
AG1 Public Comps
AG1 is still privately-owned, but its public comps include Edgewell, Chicmax Cosmetic, Jamieson Wellness, Intercos, Cosmecca Korea, Procter & Gamble Health, Mega Lifesciences, T Hasegawa, Sarantis Group and ODDITY Tech.
| Last FY | EV/Revenue | EV/EBITDA | ||||||
|---|---|---|---|---|---|---|---|---|
| Revenue | EBITDA | Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| $2.2B | $186M | 1.0x | 1.1x | 11.5x | 8.5x | |||
| $1.4B | $235M | 0.8x | 0.8x | 4.5x | 7.3x | |||
| $589M | $95M | 2.9x | 2.6x | 17.8x | 13.5x | |||
| $1.2B | $159M | 1.2x | 1.2x | 9.4x | 8.0x | |||
| $467M | $71M | 2.5x | 2.1x | 16.5x | 12.9x | |||
| $144M | $48M | 6.4x | 6.0x | 19.1x | 18.3x | |||
| $425M | $82M | 2.0x | 1.9x | 10.2x | 8.4x | |||
| $472M | $96M | 1.5x | 1.4x | 7.2x | - | |||
This data is available for Pro users. Sign up to see all AG1 competitors and their valuation data. Start Free Trial | ||||||||
Common questions about AG1
| When was AG1 founded? | AG1 was founded in 2010. |
| Where is AG1 headquartered? | AG1 is headquartered in United States. |
| Is AG1 publicly listed? | No, AG1 is a private, VC-backed company. |
| What is AG1's valuation? | AG1 was last valued at $1.2B in its undisclosed-stage round in January 2022. |
| How much funding has AG1 raised? | AG1 has raised $115M across 1 funding round. |
| What was AG1's last funding round? | AG1's last funding round was a $115M undisclosed-stage round in January 2022, led by Alpha Wave Global. |
| Who are AG1's investors? | AG1's investors include Alpha Wave Global. |
| What is AG1's revenue? | AG1's latest recorded revenue is $150M (January 2022). |
| What is AG1's revenue multiple? | AG1's latest valuation implies a 8.0x revenue multiple ($1.2B valuation on $150M of revenue). |
| Which companies are comparable to AG1? | Companies comparable to AG1 include The Good Glamm Group, Edgewell, Pharmapacks, GP Club, Jamieson Wellness and Intercos. |
See companies similar to AG1
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




